Home 2024

Archives

Figure: Generation of engineered heart tissues (Left) and a cardiac organoid (Right) derived from iPSCs. Left: Scale bar: 500 μm Right: White: Troponin T2 (cardiomyocytes), Green: GFP (fibroblasts), Red: Fibronectin, Blue: Nuclei. Scale bar: 50 μm - treatments for cardiac ailments

The role of stem cell-derived tissues in novel treatments for cardiac ailments

Curbs on animal testing mean human tissues derived from induced pluripotent stem cells offer a promising platform in discovering novel treatments for cardiac ailments.

Follow Us

Advertisements

Open Access Government

Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.

Follow Us

Resources

Quick Links

Legal & Marketing

As a Crossref Sponsored Member we are able to connect your content with a global network of online scholarly research, currently over 20,000 other organizational members from 160 countries. Crossref drive metadata exchange and support nearly 2 billion monthly API queries, facilitating global research communication.

© Adjacent Digital Politics Ltd